Results 281 to 290 of about 130,065,242 (295)

Preclinical Development of Molecular-Targeted Agents for Cancer

Nature Reviews Clinical Oncology, 2011
Alberto Ocana, Ian F Tannock, Lillian Siu   +2 more
exaly  

Combined treatments with Hadrontherapy – in vitro tests and preclinical approach

2018
G. Russo, P. Pisciotta, V. Marchese, F. P. Cammarata, L. Minafra, G. I. Forte, V. Bravatà, G. A. P. Cirrone, A. L. Fallacara, L. Maccari, F. Torrisi, G. Calabrese, R. Parenti, M. Botta, G. Cuttone   +14 more
openaire   +1 more source

In Vitro 3D Blood/Lymph-Vascularized Human Stromal Tissues for Preclinical Assays of Cancer Metastasis

Biomaterials, 2018
Akihiro Nishiguchi, Hiroshi Shimoda, Hiroshi Nishihara   +2 more
exaly  

In Vitro and in Vivo Preclinical Effects of Type I IFNs on Gliomas

Journal of Interferon and Cytokine Research, 2017
Stamatis S Papadatos, Vasiliki Galani, George A Alexiou   +2 more
exaly  

Third Generation Antivenomics: Pushing the Limits of the in Vitro Preclinical Assessment of Antivenoms

Toxins, 2017
Juan J. Calvete, Davinia Pla
exaly  

In Vitro and Preclinical Targeted Alpha Therapy for Melanoma, Breast, Prostate and Colorectal Cancers

Critical Reviews in Oncology/Hematology, 2001
Marie Ranson, B J Allen, Z Tian
exaly  

A Narrative Review of Preclinical in Vitro Studies Investigating microRNAs in Myocarditis

Current Issues in Molecular Biology
Małgorzata Wrzosek, Grzegorz Procyk, Olga Grodzka   +2 more
exaly  

Drug-Induced Nephrotoxicity: Clinical Impact and Preclinical in Vitro Models

Molecular Pharmaceutics, 2014
Daniele Zink, Anantharaman Vathsala, Ho Yee Tiong   +2 more
exaly  

Blood-Brain Barrier Models: In Vitro to in Vivo Translation in Preclinical Development of CNS-Targeting Biotherapeutics.

Expert Opinion on Drug Discovery, 2015
Danica B Stanimirovic, Mahmud Bani-Yaghoub   +1 more
exaly  

In Vitro Metabolism in Preclinical Drug Development

2010
Miia Turpeinen, Olavi Pelkonen, Ari Tolonen   +2 more
exaly